You need JavaScript to view this

International symposium on trends in radiopharmaceuticals (ISTR-2005). Book of extended synopses

Abstract

Radiopharmaceuticals, along with imaging instrumentation, are the pillars that support the edifice of clinical nuclear medicine and the former is the major driver enabling investigations of molecular phenomena for better understanding of human disease and developing effective treatments. The growth of nuclear medicine has been intimately linked to availability of new radioisotopes and the discovery of new radiopharmaceuticals. The field of radiopharmaceuticals has witnessed continuous evolution thanks to the immense contributions of scientists from diverse disciplines such as radiochemistry, inorganic chemistry, organic chemistry, biochemistry, physiology and pharmacology. Several milestones can be cited in the trajectory of this growth, which include continuing development of a plethora of {sup 99}mTc radiopharmaceuticals, automated synthesis of {sup 18}F labelled compounds, labelled peptides for accurate mapping of metastasis and the advances in radionuclide therapy. The International Symposium on Trends in Radiopharmaceuticals, ISTR-2005, under the auspices of International Atomic Energy Agency, will provide scientists and professionals working in the field of radiopharmaceuticals and related sciences an opportunity to review the exciting developments in the field. The International Atomic Energy Agency has been organizing such Symposia on Radiopharmaceuticals since 1973 and the last one was held in Lisbon, Portugal, in 1998.
Publication Date:
Jul 01, 2005
Product Type:
Technical Report
Report Number:
IAEA-CN-130
Resource Relation:
Conference: ISTR-2005: International symposium on trends in radiopharmaceuticals, Vienna (Austria), 14-18 Nov 2005; Other Information: Refs, figs, tabs
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; BIOCHEMISTRY; FLUORINE 18; IAEA; LEADING ABSTRACT; MEETINGS; NUCLEAR MEDICINE; PEPTIDES; PHARMACOLOGY; RADIOCHEMISTRY; RADIOPHARMACEUTICALS; REVIEWS; TECHNETIUM 99
OSTI ID:
20702732
Research Organizations:
International Atomic Energy Agency, Division of Physical and Chemical Sciences and Division of Human Health, Vienna (Austria)
Country of Origin:
IAEA
Language:
English
Other Identifying Numbers:
TRN: XA0501084017879
Availability:
Available from INIS in electronic form
Submitting Site:
INIS
Size:
348 pages
Announcement Date:
Apr 10, 2006

Citation Formats

None. International symposium on trends in radiopharmaceuticals (ISTR-2005). Book of extended synopses. IAEA: N. p., 2005. Web.
None. International symposium on trends in radiopharmaceuticals (ISTR-2005). Book of extended synopses. IAEA.
None. 2005. "International symposium on trends in radiopharmaceuticals (ISTR-2005). Book of extended synopses." IAEA.
@misc{etde_20702732,
title = {International symposium on trends in radiopharmaceuticals (ISTR-2005). Book of extended synopses}
author = {None}
abstractNote = {Radiopharmaceuticals, along with imaging instrumentation, are the pillars that support the edifice of clinical nuclear medicine and the former is the major driver enabling investigations of molecular phenomena for better understanding of human disease and developing effective treatments. The growth of nuclear medicine has been intimately linked to availability of new radioisotopes and the discovery of new radiopharmaceuticals. The field of radiopharmaceuticals has witnessed continuous evolution thanks to the immense contributions of scientists from diverse disciplines such as radiochemistry, inorganic chemistry, organic chemistry, biochemistry, physiology and pharmacology. Several milestones can be cited in the trajectory of this growth, which include continuing development of a plethora of {sup 99}mTc radiopharmaceuticals, automated synthesis of {sup 18}F labelled compounds, labelled peptides for accurate mapping of metastasis and the advances in radionuclide therapy. The International Symposium on Trends in Radiopharmaceuticals, ISTR-2005, under the auspices of International Atomic Energy Agency, will provide scientists and professionals working in the field of radiopharmaceuticals and related sciences an opportunity to review the exciting developments in the field. The International Atomic Energy Agency has been organizing such Symposia on Radiopharmaceuticals since 1973 and the last one was held in Lisbon, Portugal, in 1998.}
place = {IAEA}
year = {2005}
month = {Jul}
}